THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND PAROXYSMAL ATRIAL FIBRILLATION
- Authors: Babayev F.1, Volkov V.1, Khezheva F.1
-
Affiliations:
- A.L. Mysnikov Institute of Clinical Cardiology, Russian Cardiology Research-and-Production Complex
- Issue: Vol 24, No 3 (2013)
- Pages: 45-48
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115679
- ID: 115679
Cite item
Open Access
Access granted
Abstract
The paper gives the results of a trial of the antiarrhythmic and antihypertensive efficacy of sotalol used for 12 weeks in 34 patients with arterial hypertension (AH) concurrent with atrial fibrillation (AF). If the treatment was ineffective, a combination of indapamide and perindopril was added. According to the findings, sotalol may be successfully used as a drug for antiarrhythmic therapy and effective blood pressure lowering in patients with grade I-II AH and paroxysmal AF.
Keywords
Full Text
About the authors
F. Babayev
A.L. Mysnikov Institute of Clinical Cardiology, Russian Cardiology Research-and-Production Complex
Email: bosse20077@mail.ru
V. Volkov
A.L. Mysnikov Institute of Clinical Cardiology, Russian Cardiology Research-and-Production Complex
Email: bosse20077@mail.ru
F. Khezheva
A.L. Mysnikov Institute of Clinical Cardiology, Russian Cardiology Research-and-Production Complex
Email: bosse20077@mail.ru
References
- Мазур Н.А. Практическая кардиология / М.: Медпрактика, 2012.
- Wolf P., Abbott R., Kannel W. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study // Stroke. - 1991; 22: 983-8.
- Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials // Arch. Intern. Med. - 1994; 154: 1449-57.
- Kannel W., Wolf P., Benjamin E. et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates // Am. J. Cardiol. - 1998; 82: 2-9.
- Kannel W., Abbott R., Savage D. et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study // N. Engl. J Med. - 1982; 306: 1018-22.
- Krahn A., Manfreda J., Tate R. et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study // Am. J. Med. - 1995; 98: 476-84.
- Lombardo M., Zaini G., Colloca W. et al. Left ventricular hypertrophy in hypertension: functional aspects // G. Ital. Cardiol. - 1987; 17: 1039-44.
- Verdecchia P., Reboldi G., Gattobigio R. et al. Atrial fibrillation in hypertension: predictors and outcome // Hypertension. - 2003; 41: 218-23.
- Verdecchia P., Schillaci G., Borgioni C. et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension // Circulation. - 1998; 97: 48-54.
- Devereux R. Hypertensive cardiac hypertrophy: pathophysiologic and clinical characteristics. In: Laragh J.H., Brenner B.M., eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY / Raven Press. 1989; 359-77.
- Go A., Hylek E., Phillips K. et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study // JAMA. -2001; 285: 2370-5.
- Sen S., Tarazi R., Bumpus F. Reversal of cardiac hypertrophy in renal hypertensive rats: medical vs. surgical therapy // Am. J. Physiol. - 1981; 240: 408-12.
- Andersson B., Caidahl K., di Lenarda A. et al. Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy // Circulation. - 1996; 94: 673-82.
- Gibbons R., Abrams J., Chatterjee K., et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina) // Circulation. - 2003; 107: 149-58.
- Fuster V., Ryden L., Asinger R. et al. Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology // Circulation. - 2001; 104: 2118-50.
- Patel A., Dunning J. Is Sotalol more effective than standard beta-blockers for the prophylaxis of atrial fibrillation during cardiac surgery // Int. Cardiovasc. Thorac. Surg. - 2005; 4: 147-50.
Supplementary files
